Po‐Han Lin
Impact in
- Cancer Research top 10%
- Breast Cancer Treatment Studies
- Cancer Genomics and Diagnostics
-
- BRCA gene mutations in cancer
Papers in
-
- Breast Cancer Treatment Studies 9
- Cancer Genomics and Diagnostics 2
- Oncology 11
- PARP inhibition in cancer therapy 4
- HER2/EGFR in Cancer Research 3
- Cancer Risks and Factors 2
- Co-authors
- Chia-ping Su (1 shared paper)Yau‐Huei Wei (1 shared paper)Shih-Huang Lee (1 shared paper)Chiun-Sheng Huang (10 shared papers)Sung‐Hsin Kuo (6 shared papers)Ching‐Hung Lin (5 shared papers)Long‐Yuan Li (4 shared papers)Ying‐Cheng Chiang (4 shared papers)
- Journals
- Oncotarget (3 papers)Frontiers in Oncology (2 papers)Journal of Gynecologic Oncology (2 papers)Breast Cancer Research (2 papers)Supportive Care in Cancer (1 paper)
- Partner nations
- TaiwanUnited StatesChina
In The Last Decade
Po‐Han Lin
35 papers receiving 687 citations
Peers
Comparison fields: 5 of 55
- Cancer Research 142
- Genetics 152
- Hematology 46
- Oncology 74
- Cardiology and Cardiovascular Medicine 73
Countries citing papers authored by Po‐Han Lin
This map shows the geographic impact of Po‐Han Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Po‐Han Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Po‐Han Lin more than expected).
Fields of papers citing papers by Po‐Han Lin
This network shows the impact of papers produced by Po‐Han Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Po‐Han Lin. The network helps show where Po‐Han Lin may publish in the future.
Co-authors
The 25 scholars most cited alongside Po‐Han Lin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 36 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2003 | 127 | |
| 2 | 2016 | 80 | |
| 3 | 2017 | 54 | |
| 4 | 2012 | 39 | |
| 5 | 2017 | 37 | |
| 6 | 2021 | 36 | |
| 7 | 2020 | 34 | |
| 8 | Safety and efficacy of pegylated liposomal doxorubicin-based adjuvant chemotherapy in patients with stage I-III triple-negative breast cancer. | 2014 | 28 |
| 9 | 2019 | 28 | |
| 10 | 2013 | 26 | |
| 11 | 2016 | 25 | |
| 12 | 2021 | 24 | |
| 13 | 2012 | 19 | |
| 14 | 2010 | 18 | |
| 15 | 2011 | 14 | |
| 16 | Evaluation of breast cancer susceptibility loci on 2q35, 3p24, 17q23 and FGFR2 genes in Taiwanese women with breast cancer. | 2012 | 14 |
| 17 | 2013 | 12 | |
| 18 | 2022 | 11 | |
| 19 | 2011 | 9 | |
| 20 | 2017 | 9 |
About Po‐Han Lin
Po‐Han Lin is a scholar working on Cancer Research, Oncology, Genetics, Hematology and Toxicology, having authored 36 papers that have together received 699 indexed citations. Recurring topics across this work include BRCA gene mutations in cancer (11 papers), Breast Cancer Treatment Studies (9 papers), PARP inhibition in cancer therapy (4 papers), HER2/EGFR in Cancer Research (3 papers), Acute Myeloid Leukemia Research (2 papers), Cancer Genomics and Diagnostics (2 papers), Cancer Risks and Factors (2 papers) and Bioactive Compounds and Antitumor Agents (1 paper). The work is most often cited by research in Cancer Research (142 citations), Genetics (152 citations), Hematology (46 citations), Oncology (74 citations) and Cardiology and Cardiovascular Medicine (73 citations). Po‐Han Lin has collaborated with scholars based in Taiwan, United States and China. Frequent co-authors include Chia-ping Su, Yau‐Huei Wei, Shih-Huang Lee, Chiun-Sheng Huang, Sung‐Hsin Kuo, Ching‐Hung Lin, Long‐Yuan Li, Ying‐Cheng Chiang, Wen‐Fang Cheng and Chun-Yu Liu. Their work appears in journals such as Oncotarget, Frontiers in Oncology, Journal of Gynecologic Oncology, Breast Cancer Research and Supportive Care in Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.